首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1896832

腫瘤營養市場規模、佔有率和成長分析（按癌症類型、營養素類型、配方、通路、最終用戶和地區分類）－2026-2033年產業預測

Oncology Nutrition Market Size, Share, and Growth Analysis, By Cancer Type, By Nutrition Type, By Formulation, By Distribution Channel, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，腫瘤營養市場規模將達到 24.2 億美元，到 2025 年將達到 26.3 億美元，到 2033 年將達到 52.1 億美元，在預測期（2026-2033 年）內複合年成長率為 8.9%。

癌症營養市場正經歷強勁成長，這主要得益於癌症發病率的上升以及人們對營養在癌症治療中關鍵作用認知的不斷加深。這一成長主要源於接受化療和放療等治療的癌症患者數量的快速增加，而這些治療可能導致嚴重的營養缺乏。專業的飲食和營養干預對於症狀管理、體重維持和改善治療效果至關重要。此外，人們對營養在降低癌症風險和促進整體健康方面潛在作用的認知不斷提高，也推動了市場需求。主要產業參與者正積極投資研發，以提供創新產品和服務，滿足癌症患者獨特的營養需求。

腫瘤營養市場促進因素

推動腫瘤營養市場發展的關鍵因素之一是全球癌症發生率的不斷上升。由於癌症影響眾多人群，許多患者面臨營養挑戰和非自願性體重下降，這些挑戰和體重下降既由疾病本身引起，也與化療和放療等治療的副作用有關。腫瘤營養解決方案對於提供必需營養素、減輕治療副作用以及改善癌症患者的整體健康狀況和生活品質至關重要。此外，人們越來越認知到支持性治療（尤其是營養治療）在癌症治療中的重要作用，整體推動了對專業產品和服務的需求。

腫瘤營養市場的限制因素

癌症營養市場的主要阻礙因素是專為癌症患者設計的營養產品價格高。這些產品經過精心研發，旨在滿足每位癌症患者獨特的營養需求，因此研發、生產和嚴格的品管措施都增加了成本。此外，對個人化營養方案和諮詢服務的需求進一步推高了成本，並降低了這些產品的可及性。這種經濟障礙會阻礙患者的負擔能力，尤其對於低收入社區的患者而言，會限制他們在治療期間獲得所需營養支持的能力。

腫瘤營養市場趨勢

腫瘤營養市場正加速向個人化營養干預轉型，以滿足癌症患者的特定需求。這一趨勢凸顯了營養在促進康復和控制癌症症狀的重要性。利用基因譜分析和生物標記分析等先進診斷技術，醫療專業人員能夠識別與特定癌症類型和治療方案相關的獨特營養缺乏和需求。個人化營養策略旨在最佳化飲食攝取、增強免疫功能、減輕治療相關副作用，並最終提高患者的整體生活品質。這種向精準、個人化營養的轉變，標誌著腫瘤領域對整體照護的接受度正在不斷提高。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Nestle Health Science（Switzerland）
Abbott Laboratories（USA）
Danone SA（France）
Fresenius Kabi AG（Germany）
B. Braun Melsungen AG（Germany）
Mead Johnson Nutrition Company（USA）
Hormel Foods Corporation（USA）
Meiji Holdings Co., Ltd.（Japan）
Victus, Inc.（USA）
Global Health Products, Inc.（USA）
Nutritional Medicinals, LLC（USA）
Kate Farms（USA）
Ajinomoto Co., Inc.（Japan）
Abbott Nutrition（USA）
Danone Nutricia（Netherlands）
Fresenius SE & Co. KGaA（Germany）
Baxter International Inc.（USA）
Nutritional Resources Inc.（USA）

結論與建議

簡介目錄

Product Code: SQMIG35D2089

Oncology Nutrition Market size was valued at USD 2.42 Billion in 2024 and is poised to grow from USD 2.63 Billion in 2025 to USD 5.21 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

The oncology nutrition market is experiencing robust expansion, fueled by the rising incidence of cancer and an increasing understanding of the critical role nutrition plays in cancer treatment. This growth is largely attributed to the surge in cancer patients undergoing therapies like chemotherapy and radiation, which can lead to significant nutritional deficiencies. Specialized diets and nutritional interventions are essential for managing symptoms, preserving weight, and enhancing treatment outcomes for these patients. Additionally, heightened awareness regarding nutrition's potential to mitigate cancer risks and promote overall health is bolstering market demand. Key industry players are actively investing in research and development to launch innovative products and services tailored to meet the unique nutritional requirements of cancer patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Oncology Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Oncology Nutrition Market Segments Analysis

Global Oncology Nutrition Market is segmented by cancer type, nutrition type, formulation, distribution channel, end-user and region. Based on cancer type, the market is segmented into gastrointestinal cancer, lung cancer, breast cancer, blood cancer, liver cancer and others. Based on nutrition type, the market is segmented into enteral nutrition and parenteral nutrition. Based on formulation, the market is segmented into powder, liquid and tablet. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on end-user, the market is segmented into hospitals, homecare settings and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Oncology Nutrition Market

A significant factor propelling the oncology nutrition market is the rising incidence of cancer globally. As cancer affects a large number of individuals, many patients face nutritional challenges and unintended weight loss, stemming both from the illness and the adverse effects of treatments like chemotherapy and radiation. Oncology nutrition solutions are essential in delivering necessary nutrients, alleviating treatment side effects, and enhancing the general health and quality of life for those undergoing cancer therapy. Additionally, there is an increasing acknowledgment of the critical role that supportive care, particularly nutritional therapy, plays in the overall management of cancer, which further stimulates the demand for these specialized products and services.

Restraints in the Oncology Nutrition Market

A major constraint in the oncology nutrition market is the elevated pricing of specialized nutrition products tailored for cancer patients. These products are meticulously formulated to meet the distinct nutritional requirements of individuals undergoing cancer treatment, resulting in increased costs associated with research and development, production, and stringent quality control measures. Furthermore, the necessity for individualized nutrition plans and personalized counseling services exacerbates the expense, making these products less accessible. This financial barrier can hinder affordability, particularly impacting patients in lower-income areas, which may limit their ability to obtain essential nutrition support during treatment.

Market Trends of the Oncology Nutrition Market

The Oncology Nutrition market is increasingly witnessing a shift towards personalized nutrition interventions tailored to the specific needs of cancer patients. This trend highlights the critical role of nutrition in enhancing recovery and managing cancer symptoms. By leveraging advanced diagnostic techniques, such as genetic profiling and biomarker analysis, healthcare professionals can identify unique nutritional deficiencies and requirements relative to individual cancer types and treatment plans. Personalized nutrition strategies aim to optimize dietary intake, bolster immune function, alleviate treatment-related side effects, and ultimately improve the overall quality of life for patients. This movement towards precision and individualized nutrition signifies a broader embrace of holistic care within oncology.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Oncology Nutrition Market Size by Cancer Type & CAGR (2026-2033)

Market Overview
Gastrointestinal Cancer
Lung Cancer
Breast Cancer
Blood Cancer
Liver Cancer
Others

Global Oncology Nutrition Market Size by Nutrition Type & CAGR (2026-2033)

Market Overview
Enteral Nutrition
- Standard Formulas
- Disease-Specific Formulas
Parenteral Nutrition
- Total Parenteral Nutrition (TPN)
- Peripheral Parenteral Nutrition (PPN)

Global Oncology Nutrition Market Size by Formulation & CAGR (2026-2033)

Market Overview
Powder
Liquid
Tablet

Global Oncology Nutrition Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Oncology Nutrition Market Size by End-User & CAGR (2026-2033)

Market Overview
Hospitals
Homecare Settings
Specialty Clinics

Global Oncology Nutrition Market Size & CAGR (2026-2033)

North America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
- US
- Canada
Europe (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Nestle Health Science (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danone S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mead Johnson Nutrition Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hormel Foods Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meiji Holdings Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Victus, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Global Health Products, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nutritional Medicinals, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kate Farms (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ajinomoto Co., Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Nutrition (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danone Nutricia (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nutritional Resources Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments